Taiho Ventures
Funding rounds backed by Taiho Ventures.
- Funding disclosed in full
- $197.1M
- Median round
- $77M
- Rounds in calculation
- 3
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Signadori Bio Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage | €11.1MSeed+ | BiotechFrance | |||
| Crossbow Therapeutics Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers | $77MSeries B | BiotechUnited States | |||
| EpiBiologics Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo... | $107MSeries B | BiotechUnited States |